Synovial inflammation in osteoarthritis progression.


Journal

Nature reviews. Rheumatology
ISSN: 1759-4804
Titre abrégé: Nat Rev Rheumatol
Pays: United States
ID NLM: 101500080

Informations de publication

Date de publication:
05 2022
Historique:
accepted: 14 01 2022
pubmed: 16 2 2022
medline: 30 4 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

Osteoarthritis (OA) is a progressive degenerative disease resulting in joint deterioration. Synovial inflammation is present in the OA joint and has been associated with radiographic and pain progression. Several OA risk factors, including ageing, obesity, trauma and mechanical loading, play a role in OA pathogenesis, likely by modifying synovial biology. In addition, other factors, such as mitochondrial dysfunction, damage-associated molecular patterns, cytokines, metabolites and crystals in the synovium, activate synovial cells and mediate synovial inflammation. An understanding of the activated pathways that are involved in OA-related synovial inflammation could form the basis for the stratification of patients and the development of novel therapeutics. This Review focuses on the biology of the OA synovium, how the cells residing in or recruited to the synovium interact with each other, how they become activated, how they contribute to OA progression and their interplay with other joint structures.

Identifiants

pubmed: 35165404
doi: 10.1038/s41584-022-00749-9
pii: 10.1038/s41584-022-00749-9
pmc: PMC9050956
mid: NIHMS1785158
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-275

Subventions

Organisme : NIAMS NIH HHS
ID : P30 AR073761
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073324
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR064194
Pays : United States
Organisme : NIAMS NIH HHS
ID : K01 AR077111
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG070647
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR078917
Pays : United States

Informations de copyright

© 2022. Springer Nature Limited.

Références

Hunter, D. J., March, L. & Chew, M., Lancet Commission on Osteoarthritis. Osteoarthritis in 2020 and beyond — Authors’ reply. Lancet 397, 1060 (2021).
pubmed: 33743864 doi: 10.1016/S0140-6736(21)00205-1
Deshpande, B. R. et al. Number of persons with symptomatic knee osteoarthritis in the US: impact of race and ethnicity, age, sex, and obesity. Arthritis Care Res. 68, 1743–1750 (2016).
doi: 10.1002/acr.22897
Loeser, R. F., Collins, J. A. & Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412–420 (2016).
pubmed: 27192932 pmcid: 4938009 doi: 10.1038/nrrheum.2016.65
Felson, D. T. et al. Synovitis and the risk of knee osteoarthritis: the MOST Study. Osteoarthritis Cartilage 24, 458–464 (2016).
pubmed: 26432512 doi: 10.1016/j.joca.2015.09.013
Collins, J. E. et al. Semiquantitative imaging biomarkers of knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Rheumatol. 68, 2422–2431 (2016).
pubmed: 27111771 pmcid: 5599158 doi: 10.1002/art.39731
Wang, Y. et al. Knee effusion volume assessed by magnetic resonance imaging and progression of knee osteoarthritis: data from the Osteoarthritis Initiative. Rheumatology 58, 246–253 (2019).
pubmed: 30204907 doi: 10.1093/rheumatology/key274
Atukorala, I. et al. Synovitis in knee osteoarthritis: a precursor of disease? Ann. Rheum. Dis. 75, 390–395 (2016).
pubmed: 25488799 doi: 10.1136/annrheumdis-2014-205894
MacFarlane, L. A. et al. Association of changes in effusion-synovitis with progression of cartilage damage over eighteen months in patients with osteoarthritis and meniscal tear. Arthritis Rheumatol. 71, 73–81 (2019).
pubmed: 30133187 doi: 10.1002/art.40660
Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis–results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361–367 (2005).
pubmed: 15882559 doi: 10.1016/j.joca.2005.01.005
Roemer, F. W. et al. Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? Radiology 274, 810–820 (2015).
pubmed: 25279436 doi: 10.1148/radiol.14140991
Roemer, F. W. et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann. Rheum. Dis. 70, 1804–1809 (2011).
pubmed: 21791448 doi: 10.1136/ard.2011.150243
Perry, T. A. et al. Association between bone marrow lesions & synovitis and symptoms in symptomatic knee osteoarthritis. Osteoarthritis Cartilage 28, 316–323 (2020).
pubmed: 31877381 doi: 10.1016/j.joca.2019.12.002
Haugen, I. K. et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype? Osteoarthritis Cartilage 24, 647–654 (2016).
pubmed: 26620088 doi: 10.1016/j.joca.2015.11.014
Haugen, I. K. et al. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Ann. Rheum. Dis. 75, 117–123 (2016).
pubmed: 25204463 doi: 10.1136/annrheumdis-2014-205949
Mancarella, L., Addimanda, O., Cavallari, C. & Meliconi, R. Synovial inflammation drives structural damage in hand osteoarthritis: a narrative literature review. Curr. Rheumatol. Rev. 13, 43–50 (2017).
pubmed: 27632984 doi: 10.2174/1573397112666160909105903
Marshall, M., Watt, F. E., Vincent, T. L. & Dziedzic, K. Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management. Nat. Rev. Rheumatol. 14, 641–656 (2018).
pubmed: 30305701 doi: 10.1038/s41584-018-0095-4
Driban, J. B. et al. Risk factors and the natural history of accelerated knee osteoarthritis: a narrative review. BMC Musculoskelet. Disord. 21, 332 (2020).
pubmed: 32471412 pmcid: 7260785 doi: 10.1186/s12891-020-03367-2
Wyatt, L. A. et al. Molecular expression patterns in the synovium and their association with advanced symptomatic knee osteoarthritis. Osteoarthritis Cartilage 27, 667–675 (2019).
pubmed: 30597276 doi: 10.1016/j.joca.2018.12.012
Sarmanova, A. et al. Association between ultrasound-detected synovitis and knee pain: a population-based case-control study with both cross-sectional and follow-up data. Arthritis Res. Ther. 19, 281 (2017).
pubmed: 29258575 pmcid: 5738097 doi: 10.1186/s13075-017-1486-7
Hill, C. L. et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann. Rheum. Dis. 66, 1599–1603 (2007).
pubmed: 17491096 pmcid: 2095318 doi: 10.1136/ard.2006.067470
Riis, R. G. et al. The association between histological, macroscopic and magnetic resonance imaging assessed synovitis in end-stage knee osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage 25, 272–280 (2017).
pubmed: 27737813 doi: 10.1016/j.joca.2016.10.006
Abbasi, B., Pezeshki-Rad, M., Akhavan, R. & Sahebari, M. Association between clinical and sonographic synovitis in patients with painful knee osteoarthritis. Int. J. Rheum. Dis. 20, 561–566 (2017).
pubmed: 26915050 doi: 10.1111/1756-185X.12834
Baker, K. et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann. Rheum. Dis. 69, 1779–1783 (2010).
pubmed: 20472593 doi: 10.1136/ard.2009.121426
Ballegaard, C. et al. Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage 22, 933–940 (2014).
pubmed: 24821663 doi: 10.1016/j.joca.2014.04.018
Kanthawang, T. et al. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative. Skeletal Radiol. 50, 217–229 (2021).
pubmed: 32699956 doi: 10.1007/s00256-020-03550-5
Guermazi, A. et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann. Rheum. Dis. 70, 805–811 (2011).
pubmed: 21187293 doi: 10.1136/ard.2010.139618
Riis, R. G. et al. Synovitis assessed on static and dynamic contrast-enhanced magnetic resonance imaging and its association with pain in knee osteoarthritis: a cross-sectional study. Eur. J. Radiol. 85, 1099–1108 (2016).
pubmed: 27161058 doi: 10.1016/j.ejrad.2016.03.017
Bacon, K., LaValley, M. P., Jafarzadeh, S. R. & Felson, D. Does cartilage loss cause pain in osteoarthritis and if so, how much? Ann. Rheum. Dis. 79, 1105–1110 (2020).
pubmed: 32381567 doi: 10.1136/annrheumdis-2020-217363
Chevalier, X., Eymard, F. & Richette, P. Biologic agents in osteoarthritis: hopes and disappointments. Nat. Rev. Rheumatol. 9, 400–410 (2013).
pubmed: 23545735 doi: 10.1038/nrrheum.2013.44
Ansari, M. Y. et al. Genetic inactivation of ZCCHC6 suppresses interleukin-6 expression and reduces the severity of experimental osteoarthritis in mice. Arthritis Rheumatol. 71, 583–593 (2019).
pubmed: 30302948 pmcid: 6438766 doi: 10.1002/art.40751
Attur, M. et al. Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease. Ann. Rheum. Dis. 79, 400–407 (2020).
pubmed: 31852669 doi: 10.1136/annrheumdis-2019-216055
Latourte, A. et al. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis. Ann. Rheum. Dis. 76, 748–755 (2017).
pubmed: 27789465 doi: 10.1136/annrheumdis-2016-209757
Nasi, S., So, A., Combes, C., Daudon, M. & Busso, N. Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis. Ann. Rheum. Dis. 75, 1372–1379 (2016).
pubmed: 26253096 doi: 10.1136/annrheumdis-2015-207487
Kadri, A. et al. Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis. Arthritis Rheum. 58, 2379–2386 (2008).
pubmed: 18668550 doi: 10.1002/art.23638
Chevalier, X. et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 74, 1697–1705 (2015).
pubmed: 24817417 doi: 10.1136/annrheumdis-2014-205348
Kloppenburg, M. et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann. Rheum. Dis. 78, 413–420 (2019).
pubmed: 30552176 doi: 10.1136/annrheumdis-2018-213336
Persson, M. S. M., Sarmanova, A., Doherty, M. & Zhang, W. Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials. Rheumatology 57, 1830–1837 (2018).
pubmed: 29917100 pmcid: 6199417 doi: 10.1093/rheumatology/key131
Richette, P. et al. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2020-218547 (2020).
doi: 10.1136/annrheumdis-2020-218547 pubmed: 33055078
Sellam, J. & Berenbaum, F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6, 625–635 (2010).
pubmed: 20924410 doi: 10.1038/nrrheum.2010.159
Chao, J. et al. Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis. J. Rheumatol. 37, 650–655 (2010).
pubmed: 20080918 doi: 10.3899/jrheum.090575
de Lange-Brokaar, B. J. et al. Degree of synovitis on MRI by comprehensive whole knee semi-quantitative scoring method correlates with histologic and macroscopic features of synovial tissue inflammation in knee osteoarthritis. Osteoarthritis Cartilage 22, 1606–1613 (2014).
pubmed: 24365722 doi: 10.1016/j.joca.2013.12.013
Loeuille, D. et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum. 52, 3492–3501 (2005).
pubmed: 16255041 doi: 10.1002/art.21373
af Klint, E. et al. Evaluation of arthroscopy and macroscopic scoring. Arthritis Res. Ther. 11, R81 (2009).
pubmed: 19490631 pmcid: 2714131 doi: 10.1186/ar2714
Krenn, V. et al. Grading of chronic synovitis — a histopathological grading system for molecular and diagnostic pathology. Pathol. Res. Pract. 198, 317–325 (2002).
pubmed: 12092767 doi: 10.1078/0344-0338-5710261
Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358–364 (2006).
pubmed: 16978198 doi: 10.1111/j.1365-2559.2006.02508.x
Slansky, E. et al. Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology 57, 436–443 (2010).
pubmed: 20840673 doi: 10.1111/j.1365-2559.2010.03641.x
Krenn, V. et al. 15 years of the histopathological synovitis score, further development and review: a diagnostic score for rheumatology and orthopaedics. Pathol. Res. Pract. 213, 874–881 (2017).
pubmed: 28687159 doi: 10.1016/j.prp.2017.05.005
Oehler, S., Neureiter, D., Meyer-Scholten, C. & Aigner, T. Subtyping of osteoarthritic synoviopathy. Clin. Exp. Rheumatol. 20, 633–640 (2002).
pubmed: 12412193
Mathiessen, A. & Conaghan, P. G. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res. Ther. 19, 18 (2017).
pubmed: 28148295 pmcid: 5289060 doi: 10.1186/s13075-017-1229-9
Mussawy, H. et al. The histopathological synovitis score is influenced by biopsy location in patients with knee osteoarthritis. Arch. Orthop. Trauma. Surg. https://doi.org/10.1007/s00402-021-03889-x (2021).
doi: 10.1007/s00402-021-03889-x pubmed: 33837812
de Lange-Brokaar, B. J. et al. Association of pain in knee osteoarthritis with distinct patterns of synovitis. Arthritis Rheumatol. 67, 733–740 (2015).
pubmed: 25418977 doi: 10.1002/art.38965
Nanus, D. E. et al. Synovial tissue from sites of joint pain in knee osteoarthritis patients exhibits a differential phenotype with distinct fibroblast subsets. EBioMedicine https://doi.org/10.1016/j.ebiom.2021.103618 (2021).
doi: 10.1016/j.ebiom.2021.103618 pubmed: 34628351 pmcid: 8511845
Wyatt, L. A. et al. Histopathological subgroups in knee osteoarthritis. Osteoarthritis Cartilage 25, 14–22 (2017).
pubmed: 27720884 doi: 10.1016/j.joca.2016.09.021
Benito, M. J., Veale, D. J., FitzGerald, O., van den Berg, W. B. & Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263–1267 (2005).
pubmed: 15731292 pmcid: 1755629 doi: 10.1136/ard.2004.025270
Livshits, G. et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study. Arthritis Rheum. 60, 2037–2045 (2009).
pubmed: 19565477 pmcid: 2841820 doi: 10.1002/art.24598
Stannus, O. et al. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 18, 1441–1447 (2010).
pubmed: 20816981 doi: 10.1016/j.joca.2010.08.016
Labinsky, H. et al. Multiparameter analysis identifies heterogeneity in knee osteoarthritis synovial responses. Arthritis Rheumatol. 72, 598–608 (2020).
pubmed: 31702112 pmcid: 7113107 doi: 10.1002/art.41161
Chou, C. H. et al. Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis. Sci. Rep. 10, 10868 (2020).
pubmed: 32616761 pmcid: 7331607 doi: 10.1038/s41598-020-67730-y
Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019).
pubmed: 31061532 pmcid: 6602051 doi: 10.1038/s41590-019-0378-1
Klein-Wieringa, I. R. et al. Inflammatory cells in patients with endstage knee osteoarthritis: a comparison between the synovium and the infrapatellar fat pad. J. Rheumatol. 43, 771–778 (2016).
pubmed: 26980579 doi: 10.3899/jrheum.151068
Wood, M. J. et al. Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients. JCI Insight 4, e125325 (2019).
pmcid: 6413777 doi: 10.1172/jci.insight.125325
Watanabe, S., Alexander, M., Misharin, A. V. & Budinger, G. R. S. The role of macrophages in the resolution of inflammation. J. Clin. Invest. 129, 2619–2628 (2019).
pubmed: 31107246 pmcid: 6597225 doi: 10.1172/JCI124615
Gomez-Aristizabal, A., Gandhi, R., Mahomed, N. N., Marshall, K. W. & Viswanathan, S. Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study. Arthritis Res. Ther. 21, 26 (2019).
pubmed: 30658702 pmcid: 6339358 doi: 10.1186/s13075-018-1798-2
Kraus, V. B. et al. Direct in vivo evidence of activated macrophages in human osteoarthritis. Osteoarthritis Cartilage 24, 1613–1621 (2016).
pubmed: 27084348 pmcid: 4992586 doi: 10.1016/j.joca.2016.04.010
Raghu, H. et al. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. Ann. Rheum. Dis. 76, 914–922 (2017).
pubmed: 27965260 doi: 10.1136/annrheumdis-2016-210426
Bondeson, J. et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 62, 647–657 (2010).
pubmed: 20187160 doi: 10.1002/art.27290
Bondeson, J., Wainwright, S. D., Lauder, S., Amos, N. & Hughes, C. E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res. Ther. 8, R187 (2006).
pubmed: 17177994 pmcid: 1794533 doi: 10.1186/ar2099
Wu, C. L. et al. Conditional macrophage depletion increases inflammation and does not inhibit the development of osteoarthritis in obese macrophage fas-induced apoptosis-transgenic mice. Arthritis Rheumatol. 69, 1772–1783 (2017).
pubmed: 28544542 pmcid: 5611814 doi: 10.1002/art.40161
Orecchioni, M., Ghosheh, Y., Pramod, A. B. & Ley, K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front. Immunol. 10, 1084 (2019).
pubmed: 31178859 pmcid: 6543837 doi: 10.3389/fimmu.2019.01084
Viola, A., Munari, F., Sanchez-Rodriguez, R., Scolaro, T. & Castegna, A. The metabolic signature of macrophage responses. Front. Immunol. 10, 1462 (2019).
pubmed: 31333642 pmcid: 6618143 doi: 10.3389/fimmu.2019.01462
Daghestani, H. N., Pieper, C. F. & Kraus, V. B. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol. 67, 956–965 (2015).
pubmed: 25544994 pmcid: 4441094 doi: 10.1002/art.39006
Liu, B., Zhang, M., Zhao, J., Zheng, M. & Yang, H. Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp. Ther. Med. 16, 5009–5014 (2018).
pubmed: 30546406 pmcid: 6256852
Manferdini, C. et al. From osteoarthritic synovium to synovial-derived cells characterization: synovial macrophages are key effector cells. Arthritis Res. Ther. 18, 83 (2016).
pubmed: 27044395 pmcid: 4820904 doi: 10.1186/s13075-016-0983-4
Fahy, N. et al. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthritis Cartilage 22, 1167–1175 (2014).
pubmed: 24911520 doi: 10.1016/j.joca.2014.05.021
Saito, I., Koshino, T., Nakashima, K., Uesugi, M. & Saito, T. Increased cellular infiltrate in inflammatory synovia of osteoarthritic knees. Osteoarthritis Cartilage 10, 156–162 (2002).
pubmed: 11869075 doi: 10.1053/joca.2001.0494
Madsen, D. H. et al. M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J. Cell Biol. 202, 951–966 (2013).
pubmed: 24019537 pmcid: 3776354 doi: 10.1083/jcb.201301081
Dai, M., Sui, B., Xue, Y., Liu, X. & Sun, J. Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhibiting apoptosis and hypertrophy of chondrocytes. Biomaterials 180, 91–103 (2018).
pubmed: 30031224 doi: 10.1016/j.biomaterials.2018.07.011
Hoeksema, M. A. & Glass, C. K. Nature and nurture of tissue-specific macrophage phenotypes. Atherosclerosis 281, 159–167 (2019).
pubmed: 30343819 doi: 10.1016/j.atherosclerosis.2018.10.005
Young, L. et al. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum. 44, 343–350 (2001).
pubmed: 11229465 doi: 10.1002/1529-0131(200102)44:2<343::AID-ANR52>3.0.CO;2-Q
Siebelt, M. et al. Triamcinolone acetonide activates an anti-inflammatory and folate receptor-positive macrophage that prevents osteophytosis in vivo. Arthritis Res. Ther. 17, 352 (2015).
pubmed: 26637220 pmcid: 4670534 doi: 10.1186/s13075-015-0865-1
Ha, C. W. et al. A multicenter, single-blind, phase IIa clinical trial to evaluate the efficacy and safety of a cell-mediated gene therapy in degenerative knee arthritis patients. Hum. Gene Ther. Clin. Dev. 26, 125–130 (2015).
pubmed: 25760423 doi: 10.1089/humc.2014.145
Cherian, J. J. et al. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-beta1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage 23, 2109–2118 (2015).
pubmed: 26188189 doi: 10.1016/j.joca.2015.06.019
Ting, R. et al. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug. Chem. 21, 1811–1819 (2010).
pubmed: 20873712 pmcid: 2957852 doi: 10.1021/bc1001328
Yang, X. et al. Detection of osteoarthritis inflammation by single-photon emission computed tomography based on an inflammation-targeting peptide cFLFLF. Mol. Imaging Biol. 23, 895–904 (2021).
pubmed: 34031844 doi: 10.1007/s11307-021-01616-x
Meester, E. J. et al. Imaging inflammation in atherosclerotic plaques, targeting SST
pubmed: 32026330 doi: 10.1007/s12350-020-02046-y
Temple-Wong, M. M. et al. Hyaluronan concentration and size distribution in human knee synovial fluid: variations with age and cartilage degeneration. Arthritis Res. Ther. 18, 18 (2016).
pubmed: 26792492 pmcid: 4721052 doi: 10.1186/s13075-016-0922-4
Balazs, E. A. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg. Technol. Int. 12, 278–289 (2004).
pubmed: 15455338
Ni, S. et al. The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-kappaB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation. Arthritis Res. Ther. 17, 91 (2015).
pubmed: 25888873 pmcid: 4407312 doi: 10.1186/s13075-015-0605-6
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33–42 (2011).
pubmed: 21119608 doi: 10.1038/nrrheum.2010.196
Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).
pubmed: 29476097 pmcid: 5824882 doi: 10.1038/s41467-018-02892-y
Hsueh, M. F., Zhang, X., Wellman, S. S., Bolognesi, M. P. & Kraus, V. B. Synergistic roles of macrophages and neutrophils in osteoarthritis progression. Arthritis Rheumatol. 73, 89–99 (2021).
pubmed: 32783329 doi: 10.1002/art.41486
Gupta, K., Shukla, M., Cowland, J. B., Malemud, C. J. & Haqqi, T. M. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum. 56, 3326–3335 (2007).
pubmed: 17907186 doi: 10.1002/art.22879
de Lange-Brokaar, B. J. et al. Characterization of synovial mast cells in knee osteoarthritis: association with clinical parameters. Osteoarthritis Cartilage 24, 664–671 (2016).
pubmed: 26671522 doi: 10.1016/j.joca.2015.11.011
Wang, Q. et al. IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis. eLife 8, e39905 (2019).
pubmed: 31084709 pmcid: 6516833 doi: 10.7554/eLife.39905
Sousa-Valente, J. et al. Role of TrkA signalling and mast cells in the initiation of osteoarthritis pain in the monoiodoacetate model. Osteoarthritis Cartilage 26, 84–94 (2018).
pubmed: 28844566 doi: 10.1016/j.joca.2017.08.006
Enomoto, H. et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am. J. Pathol. 162, 171–181 (2003).
pubmed: 12507900 pmcid: 1851114 doi: 10.1016/S0002-9440(10)63808-4
Kennedy, A. et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum. 62, 711–721 (2010).
pubmed: 20187131 doi: 10.1002/art.27287
Kim, H. R., Lee, J. H., Kim, K. W., Kim, B. M. & Lee, S. H. The relationship between synovial fluid VEGF and serum leptin with ultrasonographic findings in knee osteoarthritis. Int. J. Rheum. Dis. 19, 233–240 (2016).
pubmed: 25529922 doi: 10.1111/1756-185X.12486
Nagao, M. et al. Vascular endothelial growth factor in cartilage development and osteoarthritis. Sci. Rep. 7, 13027 (2017).
pubmed: 29026147 pmcid: 5638804 doi: 10.1038/s41598-017-13417-w
Li, Y. S., Luo, W., Zhu, S. A. & Lei, G. H. T cells in osteoarthritis: alterations and beyond. Front. Immunol. 8, 356 (2017).
pubmed: 28424692 pmcid: 5371609
Rosshirt, N. et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. Arthritis Res. Ther. 23, 37 (2021).
pubmed: 33482899 pmcid: 7821658 doi: 10.1186/s13075-020-02410-w
Nees, T. A. et al. T helper cell infiltration in osteoarthritis-related knee pain and disability. J. Clin. Med. 9, 2423 (2020).
pmcid: 7464429 doi: 10.3390/jcm9082423
Thomas, A. C., Hubbard-Turner, T., Wikstrom, E. A. & Palmieri-Smith, R. M. Epidemiology of posttraumatic osteoarthritis. J. Athl. Train. 52, 491–496 (2017).
pubmed: 27145096 pmcid: 5488839 doi: 10.4085/1062-6050-51.5.08
Whittaker, J. L. et al. Association between MRI-defined osteoarthritis, pain, function and strength 3–10 years following knee joint injury in youth sport. Br. J. Sports Med. 52, 934–939 (2018).
pubmed: 29018061 doi: 10.1136/bjsports-2017-097576
Scanzello, C. R. et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum. 63, 391–400 (2011).
pubmed: 21279996 pmcid: 3260472 doi: 10.1002/art.30137
Pessler, F. et al. The synovitis of “non-inflammatory” orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann. Rheum. Dis. 67, 1184–1187 (2008).
pubmed: 18203762 doi: 10.1136/ard.2008.087775
Lieberthal, J., Sambamurthy, N. & Scanzello, C. R. Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartilage 23, 1825–1834 (2015).
pubmed: 26521728 pmcid: 4630675 doi: 10.1016/j.joca.2015.08.015
Davis, J. E. et al. A single recent injury is a potent risk factor for the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative. Rheumatol. Int. 37, 1759–1764 (2017).
pubmed: 28831543 pmcid: 5693623 doi: 10.1007/s00296-017-3802-6
Driban, J. B. et al. Association of knee injuries with accelerated knee osteoarthritis progression: data from the Osteoarthritis Initiative. Arthritis Care Res. 66, 1673–1679 (2014).
doi: 10.1002/acr.22359
Gelber, A. C. et al. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann. Intern. Med. 133, 321–328 (2000).
pubmed: 10979876 doi: 10.7326/0003-4819-133-5-200009050-00007
Sward, P., Frobell, R., Englund, M., Roos, H. & Struglics, A. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis) — a cross-sectional analysis. Osteoarthritis Cartilage 20, 1302–1308 (2012).
pubmed: 22874525 doi: 10.1016/j.joca.2012.07.021
Pham, T. M., Erichsen, J. L., Kowal, J. M., Overgaard, S. & Schmal, H. Elevation of pro-inflammatory cytokine levels following intra-articular fractures-a systematic review. Cells 10, 902 (2021).
pubmed: 33919965 pmcid: 8070895 doi: 10.3390/cells10040902
Pham, T. M., Frich, L. H., Lambertsen, K. L., Overgaard, S. & Schmal, H. Elevation of inflammatory cytokines and proteins after intra-articular ankle fracture: a cross-sectional study of 47 ankle fracture patients. Mediators Inflamm. 2021, 8897440 (2021).
pubmed: 33505222 pmcid: 7811423 doi: 10.1155/2021/8897440
Jacobs, C. A. et al. Dysregulated inflammatory response related to cartilage degradation after ACL injury. Med. Sci. Sports Exerc. 52, 535–541 (2020).
pubmed: 31524832 pmcid: 7024009 doi: 10.1249/MSS.0000000000002161
Adams, S. B. et al. Inflammatory microenvironment persists after bone healing in intra-articular ankle fractures. Foot Ankle Int. 38, 479–484 (2017).
pubmed: 28142266 doi: 10.1177/1071100717690427
Roemer, F. W. et al. Molecular and structural biomarkers of inflammation at two years after acute anterior cruciate ligament injury do not predict structural knee osteoarthritis at five years. Arthritis Rheumatol. 71, 238–243 (2019).
pubmed: 30079991 doi: 10.1002/art.40687
Griffin, T. M. & Guilak, F. The role of mechanical loading in the onset and progression of osteoarthritis. Exerc. Sport. Sci. Rev. 33, 195–200 (2005).
pubmed: 16239837 doi: 10.1097/00003677-200510000-00008
Fang, T., Zhou, X., Jin, M., Nie, J. & Li, X. Molecular mechanisms of mechanical load-induced osteoarthritis. Int. Orthop. 45, 1125–1136 (2021).
pubmed: 33459826 doi: 10.1007/s00264-021-04938-1
Nazet, U. et al. Housekeeping gene validation for RT-qPCR studies on synovial fibroblasts derived from healthy and osteoarthritic patients with focus on mechanical loading. PLoS One 14, e0225790 (2019).
pubmed: 31809510 pmcid: 6897414 doi: 10.1371/journal.pone.0225790
Fahy, N., Menzel, U., Alini, M. & Stoddart, M. J. Shear and dynamic compression modulates the inflammatory phenotype of human monocytes in vitro. Front. Immunol. 10, 383 (2019).
pubmed: 30891042 pmcid: 6411641 doi: 10.3389/fimmu.2019.00383
Ruffino, J. S. et al. Moderate-intensity exercise alters markers of alternative activation in circulating monocytes in females: a putative role for PPARgamma. Eur. J. Appl. Physiol. 116, 1671–1682 (2016).
pubmed: 27339155 pmcid: 4983283 doi: 10.1007/s00421-016-3414-y
Helmark, I. C. et al. Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res. Ther. 12, R126 (2010).
pubmed: 20594330 pmcid: 2945016 doi: 10.1186/ar3064
Boonstra, A. et al. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177, 7551–7558 (2006).
pubmed: 17114424 doi: 10.4049/jimmunol.177.11.7551
Yoshimura, N. et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 20, 1217–1226 (2012).
pubmed: 22796312 doi: 10.1016/j.joca.2012.06.006
Batushansky, A. et al. Fundamentals of OA. An initiative of osteoarthritis and cartilage. Chapter 9: obesity and metabolic factors in OA. Osteoarthritis Cartilage https://doi.org/10.1016/j.joca.2021.06.013 (2021).
doi: 10.1016/j.joca.2021.06.013 pubmed: 34537381
Prieto-Alhambra, D. et al. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann. Rheum. Dis. 73, 1659–1664 (2014).
pubmed: 23744977 doi: 10.1136/annrheumdis-2013-203355
Losina, E. et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res. 65, 703–711 (2013).
doi: 10.1002/acr.21898
Murphy, L. B. et al. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage 18, 1372–1379 (2010).
pubmed: 20713163 pmcid: 2998063 doi: 10.1016/j.joca.2010.08.005
Berenbaum, F., Wallace, I. J., Lieberman, D. E. & Felson, D. T. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 14, 674–681 (2018).
pubmed: 30209413 doi: 10.1038/s41584-018-0073-x
Harasymowicz, N. S. et al. Regional differences between perisynovial and infrapatellar adipose tissue depots and their response to Class II and Class III obesity in patients with osteoarthritis. Arthritis Rheumatol. 69, 1396–1406 (2017).
pubmed: 28320058 doi: 10.1002/art.40102
Duan, L. et al. Infrapatellar fat pads participate in the development of knee osteoarthritis in obese patients via the activation of the NFkappaB signaling pathway. Int. J. Mol. Med. 46, 2260–2270 (2020).
pubmed: 33125085 doi: 10.3892/ijmm.2020.4739
Takata, K. et al. Increase in tryptase and its role in the synovial membrane of overweight and obese patients with osteoarthritis of the knee. Diabetes Metab. Syndr. Obes. 13, 1491–1497 (2020).
pubmed: 32440178 pmcid: 7211312 doi: 10.2147/DMSO.S253147
Sun, A. R. et al. Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis. PLoS One 12, e0183693 (2017).
pubmed: 28859108 pmcid: 5578643 doi: 10.1371/journal.pone.0183693
Larranaga-Vera, A. et al. Increased synovial lipodystrophy induced by high fat diet aggravates synovitis in experimental osteoarthritis. Arthritis Res. Ther. 19, 264 (2017).
pubmed: 29191221 pmcid: 5709929 doi: 10.1186/s13075-017-1473-z
Yusuf, E. et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis. 69, 761–765 (2010).
pubmed: 19487215 doi: 10.1136/ard.2008.106930
Reyes, C. et al. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 68, 1869–1875 (2016).
pubmed: 27059260 pmcid: 4966641 doi: 10.1002/art.39707
Yang, W. H. et al. Leptin induces IL-6 expression through OBRl receptor signaling pathway in human synovial fibroblasts. PLoS One 8, e75551 (2013).
pubmed: 24086566 pmcid: 3785513 doi: 10.1371/journal.pone.0075551
Jafarzadeh, S. R. et al. Mediating role of bone marrow lesions, synovitis, pain sensitization, and depressive symptoms on knee pain improvement following substantial weight loss. Arthritis Rheumatol. 72, 420–427 (2020).
pubmed: 31562683 pmcid: 7050338 doi: 10.1002/art.41125
Gudbergsen, H. et al. Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients: a prospective cohort study. BMC Musculoskelet. Disord. 14, 106 (2013).
pubmed: 23522337 pmcid: 3618315 doi: 10.1186/1471-2474-14-106
Henriksen, M. et al. Structural changes in the knee during weight loss maintenance after a significant weight loss in obese patients with osteoarthritis: a report of secondary outcome analyses from a randomized controlled trial. Osteoarthritis Cartilage 22, 639–646 (2014).
pubmed: 24636948 doi: 10.1016/j.joca.2014.03.003
Daugaard, C. L. et al. The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis: a prospective cohort study. Osteoarthritis Cartilage 28, 766–773 (2020).
pubmed: 32165240 doi: 10.1016/j.joca.2020.02.837
Piva, S. R. et al. Links between osteoarthritis and diabetes: implications for management from a physical activity perspective. Clin. Geriatr. Med. 31, 67–87 (2015).
pubmed: 25453302 doi: 10.1016/j.cger.2014.08.019
Schett, G. et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 36, 403–409 (2013).
pubmed: 23002084 pmcid: 3554306 doi: 10.2337/dc12-0924
Louati, K., Vidal, C., Berenbaum, F. & Sellam, J. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open 1, e000077 (2015).
pubmed: 26535137 pmcid: 4613158 doi: 10.1136/rmdopen-2015-000077
Niu, J., Clancy, M., Aliabadi, P., Vasan, R. & Felson, D. T. Metabolic syndrome, its components, and knee osteoarthritis: the Framingham Osteoarthritis Study. Arthritis Rheumatol. 69, 1194–1203 (2017).
pubmed: 28257604 pmcid: 5449217 doi: 10.1002/art.40087
Monira Hussain, S. et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study. Semin. Arthritis Rheum. 43, 429–436 (2014).
pubmed: 24012045 doi: 10.1016/j.semarthrit.2013.07.013
Kuusalo, L. et al. Metabolic osteoarthritis — relation of diabetes and cardiovascular disease with knee osteoarthritis. Osteoarthritis Cartilage 29, 230–234 (2021).
pubmed: 33253888 doi: 10.1016/j.joca.2020.09.010
Rogers-Soeder, T. S. et al. Association of diabetes mellitus and biomarkers of abnormal glucose metabolism with incident radiographic knee osteoarthritis. Arthritis Care Res. 72, 98–106 (2020).
doi: 10.1002/acr.23809
Hamada, D. et al. Suppressive effects of insulin on tumor necrosis factor-dependent early osteoarthritic changes associated with obesity and type 2 diabetes mellitus. Arthritis Rheumatol. 68, 1392–1402 (2016).
pubmed: 26713606 pmcid: 4882234 doi: 10.1002/art.39561
Griffin, T. M. & Huffman, K. M. Editorial: insulin resistance: releasing the brakes on synovial inflammation and osteoarthritis? Arthritis Rheumatol. 68, 1330–1333 (2016).
pubmed: 26749517 pmcid: 5371020 doi: 10.1002/art.39586
Tsai, C. H. et al. High glucose induces vascular endothelial growth factor production in human synovial fibroblasts through reactive oxygen species generation. Biochim. Biophys. Acta 1830, 2649–2658 (2013).
pubmed: 23274526 doi: 10.1016/j.bbagen.2012.12.017
Steenvoorden, M. M. et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 54, 253–263 (2006).
pubmed: 16385542 doi: 10.1002/art.21523
Veronese, N. et al. The relationship between the dietary inflammatory index and prevalence of radiographic symptomatic osteoarthritis: data from the Osteoarthritis Initiative. Eur. J. Nutr. 58, 253–260 (2019).
pubmed: 29209774 doi: 10.1007/s00394-017-1589-6
Wang, X. et al. Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthritis Cartilage 25, 1304–1312 (2017).
pubmed: 28274889 doi: 10.1016/j.joca.2017.02.804
Perry, T. A. et al. Effect of Vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis. BMC Musculoskelet. Disord. 20, 76 (2019).
pubmed: 30764805 pmcid: 6376763 doi: 10.1186/s12891-019-2424-4
Wang, Z. et al. Effectiveness of curcuma longa extract for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Ann. Intern. Med. 173, 861–869 (2020).
pubmed: 32926799 doi: 10.7326/M20-0990
Veronese, N. et al. Mediterranean diet and knee osteoarthritis outcomes: a longitudinal cohort study. Clin. Nutr. 38, 2735–2739 (2019).
pubmed: 30553579 doi: 10.1016/j.clnu.2018.11.032
Xu, C. et al. Dietary patterns and progression of knee osteoarthritis: data from the osteoarthritis initiative. Am. J. Clin. Nutr. 111, 667–676 (2020).
pubmed: 31912140 pmcid: 7049524 doi: 10.1093/ajcn/nqz333
Ulici, V. et al. Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice. Osteoarthritis Cartilage 26, 1098–1109 (2018).
pubmed: 29857156 pmcid: 7970023 doi: 10.1016/j.joca.2018.05.016
Dunn, C. M. et al. Identification of cartilage microbial DNA signatures and associations with knee and hip osteoarthritis. Arthritis Rheumatol. 72, 1111–1122 (2020).
pubmed: 31961065 pmcid: 7336391 doi: 10.1002/art.41210
Zhao, Y. et al. Detection and characterization of bacterial nucleic acids in culture-negative synovial tissue and fluid samples from rheumatoid arthritis or osteoarthritis patients. Sci. Rep. 8, 14305 (2018).
pubmed: 30250232 pmcid: 6155189 doi: 10.1038/s41598-018-32675-w
Schott, E. M. et al. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight 3, e95997 (2018).
pmcid: 5931133 doi: 10.1172/jci.insight.95997
Huang, Z. Y., Stabler, T., Pei, F. X. & Kraus, V. B. Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthritis Cartilage 24, 1769–1775 (2016).
pubmed: 27216281 pmcid: 5026878 doi: 10.1016/j.joca.2016.05.008
Mohammad, S. & Thiemermann, C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front. Immunol. 11, 594150 (2020).
pubmed: 33505393 doi: 10.3389/fimmu.2020.594150
Fuke, N., Nagata, N., Suganuma, H. & Ota, T. Regulation of gut microbiota and metabolic endotoxemia with dietary factors. Nutrients 11, 2277 (2019).
pmcid: 6835897 doi: 10.3390/nu11102277
Boer, C. G. et al. Intestinal microbiome composition and its relation to joint pain and inflammation. Nat. Commun. 10, 4881 (2019).
pubmed: 31653850 pmcid: 6814863 doi: 10.1038/s41467-019-12873-4
Mao, X., Fu, P., Wang, L. & Xiang, C. Mitochondria: potential targets for osteoarthritis. Front. Med. 7, 581402 (2020).
doi: 10.3389/fmed.2020.581402
Geurts, J. et al. Prematurely aging mitochondrial DNA mutator mice display subchondral osteopenia and chondrocyte hypertrophy without further osteoarthritis features. Sci. Rep. 10, 1296 (2020).
pubmed: 31992827 pmcid: 6987232 doi: 10.1038/s41598-020-58385-w
Torroni, A. et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 144, 1835–1850 (1996).
pubmed: 8978068 pmcid: 1207732 doi: 10.1093/genetics/144.4.1835
Da Sylva, T. R., Connor, A., Mburu, Y., Keystone, E. & Wu, G. E. Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res. Ther. 7, R844–R851 (2005).
pubmed: 15987486 pmcid: 1175034 doi: 10.1186/ar1752
Van den Bossche, J. et al. mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 17, 684–696 (2016).
pubmed: 27732846 doi: 10.1016/j.celrep.2016.09.008
Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775–781 (2017).
pubmed: 28436958 pmcid: 5785239 doi: 10.1038/nm.4324
Yohn, C. O. B., et al. Senescent synoviocytes in knee osteoarthritis correlate with disease biomarkers, synovitis, and knee pain [abstract]. Arthritis Rheumatol. https://acrabstracts.org/abstract/senescent-synoviocytes-in-knee-osteoarthritis-correlate-with-disease-biomarkers-synovitis-and-knee-pain/ (2019).
Anderson, J. R. et al.
pubmed: 30229649 pmcid: 6220363 doi: 10.1021/acs.jproteome.8b00455
Farrell, A. J., Blake, D. R., Palmer, R. M. & Moncada, S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219–1222 (1992).
pubmed: 1466599 pmcid: 1012459 doi: 10.1136/ard.51.11.1219
Melchiorri, C. et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 41, 2165–2174 (1998).
pubmed: 9870873 doi: 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O
Abramson, S. B. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res. Ther. 10, S2 (2008).
pubmed: 19007427 pmcid: 2582805 doi: 10.1186/ar2463
Pelletier, J. P. et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J. Rheumatol. 26, 2002–2014 (1999).
pubmed: 10493683
Hellio le Graverand, M. P. et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann. Rheum. Dis. 72, 187–195 (2013).
pubmed: 23144445 doi: 10.1136/annrheumdis-2012-202239
Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496, 238–242 (2013).
pubmed: 23535595 pmcid: 4031686 doi: 10.1038/nature11986
Keiran, N. et al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nat. Immunol. 20, 581–592 (2019).
pubmed: 30962591 doi: 10.1038/s41590-019-0372-7
Li, Y. et al. Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1alpha/VEGF axis. Free Radic. Biol. Med. 126, 1–14 (2018).
pubmed: 30030103 doi: 10.1016/j.freeradbiomed.2018.07.009
Wojdasiewicz, P., Poniatowski, L. A. & Szukiewicz, D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014, 561459 (2014).
pubmed: 24876674 pmcid: 4021678 doi: 10.1155/2014/561459
Futani, H. et al. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J. Immunother. 25, S61–S64 (2002).
pubmed: 12048352 doi: 10.1097/00002371-200203001-00009
Attur, M. et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J. Immunol. 181, 5082–5088 (2008).
pubmed: 18802112 doi: 10.4049/jimmunol.181.7.5082
Valdes, A. M. et al. Omega-6 oxylipins generated by soluble epoxide hydrolase are associated with knee osteoarthritis. J. Lipid Res. 59, 1763–1770 (2018).
pubmed: 29986999 pmcid: 6121933 doi: 10.1194/jlr.P085118
Lambert, C. et al. The damage-associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature. Front. Med. 7, 607186 (2020).
doi: 10.3389/fmed.2020.607186
Millerand, M., Berenbaum, F. & Jacques, C. Danger signals and inflammaging in osteoarthritis. Clin. Exp. Rheumatol. 37, 48–56 (2019).
pubmed: 31621566
Heinola, T. et al. High mobility group box-1 (HMGB-1) in osteoarthritic cartilage. Clin. Exp. Rheumatol. 28, 511–518 (2010).
pubmed: 20659415
Li, Z. C. et al. Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis. Clin. Invest. Med. 34, E298 (2011).
pubmed: 21968272 doi: 10.25011/cim.v34i5.15673
Ke, X. et al. Synovial fluid HMGB-1 levels are associated with osteoarthritis severity. Clin. Lab. 61, 809–818 (2015).
pubmed: 26299081 doi: 10.7754/Clin.Lab.2015.141205
Aulin, C., Lassacher, T., Palmblad, K. & Erlandsson Harris, H. Early stage blockade of the alarmin HMGB1 reduces cartilage destruction in experimental OA. Osteoarthritis Cartilage 28, 698–707 (2020).
pubmed: 31982563 doi: 10.1016/j.joca.2020.01.003
Lambrecht, S., Juchtmans, N. & Elewaut, D. Heat-shock proteins in stromal joint tissues: innocent bystanders or disease-initiating proteins? Rheumatology 53, 223–232 (2014).
pubmed: 23955645 doi: 10.1093/rheumatology/ket277
Takahashi, K. et al. Localization of heat shock protein in osteoarthritic cartilage. Scand. J. Rheumatol. 26, 368–375 (1997).
pubmed: 9385349 doi: 10.3109/03009749709065701
Ngarmukos, S., Scaramuzza, S., Theerawattanapong, N., Tanavalee, A. & Honsawek, S. Circulating and synovial fluid heat shock protein 70 are correlated with severity in knee osteoarthritis. Cartilage 11, 323–328 (2020).
pubmed: 30024275 doi: 10.1177/1947603518790075
Son, Y. O., Kim, H. E., Choi, W. S., Chun, C. H. & Chun, J. S. RNA-binding protein ZFP36L1 regulates osteoarthritis by modulating members of the heat shock protein 70 family. Nat. Commun. 10, 77 (2019).
pubmed: 30622281 pmcid: 6325149 doi: 10.1038/s41467-018-08035-7
Lambert, C. et al. Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol. 66, 960–968 (2014).
pubmed: 24757147 pmcid: 4033569 doi: 10.1002/art.38315
Schelbergen, R. F. et al. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis. Ann. Rheum. Dis. 75, 218–225 (2016).
pubmed: 25180294 doi: 10.1136/annrheumdis-2014-205480
Ruan, G. et al. Associations between serum S100A8/S100A9 and knee symptoms, joint structures and cartilage enzymes in patients with knee osteoarthritis. Osteoarthritis Cartilage 27, 99–105 (2019).
pubmed: 30240939 doi: 10.1016/j.joca.2018.08.020
Addimanda, O. et al. Elevated serum levels of alarmin S100A8/A9 in patients with hand osteoarthritis. Clin. Exp. Rheumatol. 37, 885 (2019).
pubmed: 31074722
Daheshia, M. & Yao, J. Q. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J. Rheumatol. 35, 2306–2312 (2008).
pubmed: 18925684 doi: 10.3899/jrheum.080346
Inoue, H. et al. High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis. Bone 42, 1102–1110 (2008).
pubmed: 18374640 doi: 10.1016/j.bone.2008.01.031
McAllister, M. J., Chemaly, M., Eakin, A. J., Gibson, D. S. & McGilligan, V. E. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthritis Cartilage 26, 612–619 (2018).
pubmed: 29499288 doi: 10.1016/j.joca.2018.02.901
Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296–300 (2010).
pubmed: 20075245 doi: 10.1126/science.1184003
Zhong, Z. et al. NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164, 896–910 (2016).
pubmed: 26919428 pmcid: 4769378 doi: 10.1016/j.cell.2015.12.057
Sanchez-Lopez, E. et al. Choline uptake and metabolism modulate macrophage IL-1beta and IL-18 production. Cell Metab. 29, 1350–1362.e7 (2019).
pubmed: 30982734 pmcid: 6675591 doi: 10.1016/j.cmet.2019.03.011
Zhong, Z. et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 560, 198–203 (2018).
pubmed: 30046112 pmcid: 6329306 doi: 10.1038/s41586-018-0372-z
Jin, C. et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc. Natl Acad. Sci. USA 108, 14867–14872 (2011).
pubmed: 21856950 pmcid: 3169126 doi: 10.1073/pnas.1111101108
Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
pubmed: 16407889 doi: 10.1038/nature04516
Denoble, A. E. et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc. Natl Acad. Sci. USA 108, 2088–2093 (2011).
pubmed: 21245324 pmcid: 3033282 doi: 10.1073/pnas.1012743108
Elsaid, K. A. et al. The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model. Osteoarthritis Cartilage 23, 114–121 (2015).
pubmed: 25219670 doi: 10.1016/j.joca.2014.09.006
Schieker, M. et al. Effects of interleukin-1beta inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 173, 509–515 (2020).
pubmed: 32744862 pmcid: 8503784 doi: 10.7326/M20-0527
Lane, N. & Felson, D. A promising treatment for osteoarthritis? Ann. Intern. Med. 173, 580–581 (2020).
pubmed: 32744863 doi: 10.7326/M20-4938
Chevalier, X. et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 61, 344–352 (2009).
pubmed: 19248129 doi: 10.1002/art.24096
Fu, Z. et al. Interleukin-18-induced inflammatory responses in synoviocytes and chondrocytes from osteoarthritic patients. Int. J. Mol. Med. 30, 805–810 (2012).
pubmed: 22825306 doi: 10.3892/ijmm.2012.1073
Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245–254 (2017).
pubmed: 27932073 doi: 10.1016/j.tibs.2016.10.004
Wang, Q. et al. Identification of a central role for complement in osteoarthritis. Nat. Med. 17, 1674–1679 (2011).
pubmed: 22057346 pmcid: 3257059 doi: 10.1038/nm.2543
Assirelli, E. et al. Complement expression and activation in osteoarthritis joint compartments. Front. Immunol. 11, 535010 (2020).
pubmed: 33193305 pmcid: 7658426 doi: 10.3389/fimmu.2020.535010
Li, Z., Huang, Z. & Bai, L. Cell interplay in osteoarthritis. Front. Cell Dev. Biol. 9, 720477 (2021).
pubmed: 34414194 pmcid: 8369508 doi: 10.3389/fcell.2021.720477
Dreier, R., Wallace, S., Fuchs, S., Bruckner, P. & Grassel, S. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J. Cell Sci. 114, 3813–3822 (2001).
pubmed: 11719548 doi: 10.1242/jcs.114.21.3813
Hamasaki, M. et al. Transcriptional profiling of murine macrophages stimulated with cartilage fragments revealed a strategy for treatment of progressive osteoarthritis. Sci. Rep. 10, 7558 (2020).
pubmed: 32371954 pmcid: 7200748 doi: 10.1038/s41598-020-64515-1
Silverstein, A. M. et al. Toward understanding the role of cartilage particulates in synovial inflammation. Osteoarthritis Cartilage 25, 1353–1361 (2017).
pubmed: 28365462 pmcid: 5554538 doi: 10.1016/j.joca.2017.03.015
Roemer, F. W. et al. What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative. Arthritis Rheumatol. 67, 2085–2096 (2015).
pubmed: 25940308 pmcid: 4519416 doi: 10.1002/art.39176
Hugle, T. & Geurts, J. What drives osteoarthritis?-synovial versus subchondral bone pathology. Rheumatology 56, 1461–1471 (2017).
pubmed: 28003493
Hu, W., Chen, Y., Dou, C. & Dong, S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann. Rheum. Dis. 80, 413–422 (2020).
doi: 10.1136/annrheumdis-2020-218089
Yang, C. C., Lin, C. Y., Wang, H. S. & Lyu, S. R. Matrix metalloproteases and tissue inhibitors of metalloproteinases in medial plica and pannus-like tissue contribute to knee osteoarthritis progression. PLoS One 8, e79662 (2013).
pubmed: 24223987 pmcid: 3817135 doi: 10.1371/journal.pone.0079662
Furuzawa-Carballeda, J., Macip-Rodriguez, P. M. & Cabral, A. R. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin. Exp. Rheumatol. 26, 554–560 (2008).
pubmed: 18799084
Yusup, A. et al. Bone marrow lesions, subchondral bone cysts and subchondral bone attrition are associated with histological synovitis in patients with end-stage knee osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage 23, 1858–1864 (2015).
pubmed: 26028139 doi: 10.1016/j.joca.2015.05.017
Aso, K. et al. Associations of symptomatic knee osteoarthritis with histopathologic features in subchondral bone. Arthritis Rheumatol. 71, 916–924 (2019).
pubmed: 30663865 doi: 10.1002/art.40820
Arepati, A. I. et al. Osteophyte formation is associated with synovitis in osteoarthritis — the Bunkyo Health Study. Osteoarthritis Cartilage 28, S86–S527 (2020).
doi: 10.1016/j.joca.2020.02.182
Blom, A. B. et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 12, 627–635 (2004).
pubmed: 15262242 doi: 10.1016/j.joca.2004.03.003
van Lent, P. L. et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum. 50, 103–111 (2004).
pubmed: 14730606 doi: 10.1002/art.11422
Blaney Davidson, E. N. et al. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum. 56, 4065–4073 (2007).
pubmed: 18050218 doi: 10.1002/art.23034
Remst, D. F., Blaney Davidson, E. N. & van der Kraan, P. M. Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness. Rheumatology 54, 1954–1963 (2015).
pubmed: 26175472 doi: 10.1093/rheumatology/kev228
van Helvoort, E. M., Eijkelkamp, N., Lafeber, F. & Mastbergen, S. C. Expression of granulocyte macrophage-colony stimulating factor and its receptor in the synovium of osteoarthritis patients is negatively correlated with pain. Rheumatology 59, 3452–3457 (2020).
pubmed: 32365364 doi: 10.1093/rheumatology/keaa199
Wise, B. L., Seidel, M. F. & Lane, N. E. The evolution of nerve growth factor inhibition in clinical medicine. Nat. Rev. Rheumatol. 17, 34–46 (2021).
pubmed: 33219344 doi: 10.1038/s41584-020-00528-4
Stoppiello, L. A. et al. Structural associations of symptomatic knee osteoarthritis. Arthritis Rheumatol. 66, 3018–3027 (2014).
pubmed: 25049144 pmcid: 4309484 doi: 10.1002/art.38778
Cohen, S. B. et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res. Ther. 13, R125 (2011).
pubmed: 21801403 pmcid: 3239365 doi: 10.1186/ar3430
Vincent, T. L. Peripheral pain mechanisms in osteoarthritis. Pain 161, S138–S146 (2020).
pubmed: 33090747 pmcid: 7434216 doi: 10.1097/j.pain.0000000000001923
Bratus-Neuenschwander, A. et al. Pain-associated transcriptome changes in synovium of knee osteoarthritis patients. Genes (Basel) 9, 338 (2018).
doi: 10.3390/genes9070338
Attard, V. et al. Quantification of intra-articular fibrosis in patients with stiff knee arthroplasties using metal-reduction MRI. Bone Jt. J. 102-B, 1331–1340 (2020).
doi: 10.1302/0301-620X.102B10.BJJ-2020-0841.R1
Kalson, N. S. et al. International consensus on the definition and classification of fibrosis of the knee joint. Bone Jt. J. 98-B, 1479–1488 (2016).
doi: 10.1302/0301-620X.98B10.37957
Toms, J. et al. Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an
pubmed: 32332144 doi: 10.2967/jnumed.120.242958
Kerna, I. et al. The ADAM12 is upregulated in synovitis and postinflammatory fibrosis of the synovial membrane in patients with early radiographic osteoarthritis. Jt. Bone Spine 81, 51–56 (2014).
doi: 10.1016/j.jbspin.2013.03.007
Remst, D. F. et al. Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis. Arthritis Rheumatol. 66, 647–656 (2014).
pubmed: 24574225 doi: 10.1002/art.38266
Rim, Y. A. & Ju, J. H. The role of fibrosis in osteoarthritis progression. Life (Basel) 11, 3 (2020).
Bastiaansen-Jenniskens, Y. M. et al. Stimulation of fibrotic processes by the infrapatellar fat pad in cultured synoviocytes from patients with osteoarthritis: a possible role for prostaglandin f2alpha. Arthritis Rheum. 65, 2070–2080 (2013).
pubmed: 23666869 doi: 10.1002/art.37996
Eymard, F. et al. Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis. Ann. Rheum. Dis. 76, 1142–1148 (2017).
pubmed: 28298375 doi: 10.1136/annrheumdis-2016-210478
Davis, J. E. et al. Effusion-synovitis and infrapatellar fat pad signal intensity alteration differentiate accelerated knee osteoarthritis. Rheumatology 58, 418–426 (2019).
pubmed: 30346594 doi: 10.1093/rheumatology/key305
Inomata, K. et al. Time course analyses of structural changes in the infrapatellar fat pad and synovial membrane during inflammation-induced persistent pain development in rat knee joint. BMC Musculoskelet. Disord. 20, 8 (2019).
pubmed: 30611247 pmcid: 6320593 doi: 10.1186/s12891-018-2391-1
Barboza, E. et al. Profibrotic infrapatellar fat pad remodeling without M1 macrophage polarization precedes knee osteoarthritis in mice with diet-induced obesity. Arthritis Rheumatol. 69, 1221–1232 (2017).
pubmed: 28141918 pmcid: 5449220 doi: 10.1002/art.40056
de Jong, A. J. et al. Lack of high BMI-related features in adipocytes and inflammatory cells in the infrapatellar fat pad (IFP). Arthritis Res. Ther. 19, 186 (2017).
pubmed: 28800775 pmcid: 5553811 doi: 10.1186/s13075-017-1395-9
Warmink, K. et al. High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury. Osteoarthritis Cartilage 28, 593–602 (2020).
pubmed: 32222415 doi: 10.1016/j.joca.2020.03.008
Takano, S. et al. Transforming growth factor-beta stimulates nerve growth factor production in osteoarthritic synovium. BMC Musculoskelet. Disord. 20, 204 (2019).
pubmed: 31077183 pmcid: 6511148 doi: 10.1186/s12891-019-2595-z
Blaney Davidson, E. N. et al. TGF-beta is a potent inducer of nerve growth factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain? Osteoarthritis Cartilage 3, 478–486 (2015).
doi: 10.1016/j.joca.2014.12.005
Grässel, S. & Muschter, D. Recent advances in the treatment of osteoarthritis. F1000Res. 9, F1000 (2020).
pubmed: 32419923 pmcid: 7199286 doi: 10.12688/f1000research.22115.1
Vincent, T. L. Of mice and men: converging on a common molecular understanding of osteoarthritis. Lancet Rheumatol. 2, e633–e645 (2020).
pubmed: 32989436 pmcid: 7511206 doi: 10.1016/S2665-9913(20)30279-4
Wang, X., Hunter, D. J., Jin, X. & Ding, C. The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials. Osteoarthritis Cartilage 26, 165–174 (2018).
pubmed: 29224742 doi: 10.1016/j.joca.2017.11.015
Roemer, F. W. et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage 18, 1269–1274 (2010).
pubmed: 20691796 doi: 10.1016/j.joca.2010.07.008
Shakoor, D. et al. Are contrast-enhanced and non-contrast MRI findings reflecting synovial inflammation in knee osteoarthritis: a meta-analysis of observational studies. Osteoarthritis Cartilage 28, 126–136 (2020).
pubmed: 31678664 doi: 10.1016/j.joca.2019.10.008
Takase, K. et al. Simultaneous evaluation of long-lasting knee synovitis in patients undergoing arthroplasty by power Doppler ultrasonography and contrast-enhanced MRI in comparison with histopathology. Clin. Exp. Rheumatol. 30, 85–92 (2012).
pubmed: 22325923
Walther, M. et al. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 44, 331–338 (2001).
pubmed: 11229463 doi: 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0
Tarhan, S. & Unlu, Z. Magnetic resonance imaging and ultrasonographic evaluation of the patients with knee osteoarthritis: a comparative study. Clin. Rheumatol. 22, 181–188 (2003).
pubmed: 14505208 doi: 10.1007/s10067-002-0694-x

Auteurs

Elsa Sanchez-Lopez (E)

Department of Orthopaedic Surgery, University of California San Diego, San Diego, CA, USA.

Roxana Coras (R)

Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, CA, USA.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.

Alyssa Torres (A)

Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, CA, USA.

Nancy E Lane (NE)

Division of Rheumatology, Department of Medicine, University of California Davis, Davis, CA, USA.

Monica Guma (M)

Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, CA, USA. mguma@health.ucsd.edu.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain. mguma@health.ucsd.edu.
San Diego VA Healthcare Service, San Diego, CA, USA. mguma@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH